Search

Your search keyword '"Cohen, Victor"' showing total 508 results

Search Constraints

Start Over You searched for: Author "Cohen, Victor" Remove constraint Author: "Cohen, Victor"
508 results on '"Cohen, Victor"'

Search Results

2. Adaptive Annealed Importance Sampling with Constant Rate Progress

4. Future memories are not needed for large classes of POMDPs

7. Integer programming for weakly coupled stochastic dynamic programs with partial information

9. Two generalizations of Markov blankets

10. Integer programming on the junction tree polytope for influence diagrams

11. Linear Programming for Decision Processes with Partial Information

12. Patient-reported outcomes in a phase II, North American study of alectinib in patients with ALK-positive, crizotinib-resistant, non-small cell lung cancer

14. Europe 1992: Road block or two-way street?

16. Choosing Wisely and Promoting High-Value Care and Staff Safety During the COVID-19 Pandemic in a Large Safety Net System

17. Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)

19. Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibition

20. Supplementary Figure 1 from Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes

21. Supplementary Table 4 from Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes

22. Supplementary Table 3 from Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes

23. Supplementary Table 1 from Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes

24. Supplementary Figure 2 from Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes

25. Supplementary Table 2 from Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes

27. The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer over a 2-Year Period at a Canadian Academic Center

28. Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial

31. The longitudinal impact of COVID-19 on the diagnosis and treatment of lung cancer at a Canadian academic center: Interim analysis from a retrospective chart review.

32. Immuno-multiple reaction monitoring (iMRM) for quantitation of PD-L1 and PD-1-signaling proteins in non-small cell lung carcinoma (NSCLC).

34. sj-docx-1-tam-10.1177_17588359221112696 – Supplemental material for The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer

37. The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer

45. Integer programming for influence diagrams and airline maintenance problems

48. Intelligent Design: A Fable

49. Additional file 1 of Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibition

50. Additional file 3 of Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibition

Catalog

Books, media, physical & digital resources